Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
about
Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas.Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates.Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas.Epidemiology and therapies for metastatic sarcomaSurgical management of retroperitoneal and pelvic sarcomas.Surgical treatment of retroperitoneal liposarcoma.Retroperitoneal sarcomas- a challenging problem.Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.Pleomorphous leiomyosarcoma of the mesocolon: a case report.Current concepts in multimodality therapy for retroperitoneal sarcoma.Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.Combined modalities approach for localized adult extremity soft-tissue sarcoma.Effectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities.Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative StudyManagement of a catecholamine-secreting paraganglioma requiring aortic reconstruction.Role of chemotherapy in the management of soft tissue sarcomas.Current diagnosis and management of retroperitoneal sarcoma.Chemotherapy for osteosarcoma - where does it come from? What is it? Where is it going?Outcomes in the management of adult soft tissue sarcomas.Biopsy techniques for soft tissue and bowel sarcomas.Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axisLooking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.Practical Issues for Retroperitoneal Sarcoma.Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells.Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.Can Abdominal Computed Tomography Imaging Help Accurately Identify a Dedifferentiated Component in a Well-Differentiated Liposarcoma?Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.Size-based clinical response evaluation is insufficient to assess clinical response of sarcomas treated with isolated limb perfusion with TNF-α and melphalan.Predictors of surgical quality for retroperitoneal sarcoma: Volume matters.Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk.
P2860
Q33309291-F324A626-D6F5-4976-87CF-E28BF11FDA67Q33398802-CC7B5D9E-7221-4C59-9FB5-3240A210CE1DQ33410972-5205C145-E532-447F-B20F-72DD89CFDBADQ33641267-FD72494A-F3FB-4FD2-A2FE-68A9F667F8D4Q34652142-2D6A7A4B-7EB8-437D-A716-5302F53695DEQ35224619-36D33950-5453-42F9-85A5-AFA2BB799CD0Q35502750-4F24AA3B-15EB-4DE0-8B04-EC3E60082952Q36240424-C153B4B9-EECD-4E39-BE2F-B3F44FB8AA25Q36454797-813C6CD0-6868-4C5F-BB28-E616A1674E9BQ36626427-134FFA1B-B804-44A0-B8F9-63BDB8464AD4Q36731422-7F371F26-FEC7-4693-8829-787D2C93D886Q36973569-E6F3C6C8-9E6B-4844-A8B6-E3CF05DEE674Q37008868-45E91B5D-6490-438C-95E0-8101556E8CB8Q37130237-BD83D0CA-11AC-498D-A8C2-A3F32793E09FQ37426036-3D2FCF7A-500C-4032-9947-83EB4BE0BA2FQ37662615-4FC26F72-53C9-408D-9338-2716A23D2B1EQ37687389-5438D261-2EB5-4C02-85B0-C8A77B60F6BEQ37888460-E78C25D1-9FA2-4768-A92D-DF9B875C7AFFQ38126943-A0F666E8-C691-4CB1-8FA1-352977BC22A4Q38223237-9749F65A-3021-4BB5-9D3E-B53AC322F82EQ38348576-72A06C16-93B4-42C4-A555-B351665AAB12Q38737938-17972F9E-0D29-4C39-B057-3AAA1B34729FQ38840133-EF8E8E15-CF56-411A-BD1A-BF761E2402EBQ38936009-8D2F9BBB-867B-4132-A6F2-75D0847D6C29Q39192067-C87B1604-A2E3-4C9A-A2CD-AADC9CF79CA8Q40992002-8A292320-7B72-4729-B88F-18B074FA76DCQ42746834-A190BAA1-9920-4DD5-AE9B-3ED4F7F484B3Q45133928-239353E3-47FC-45FD-9496-2CAA8A4E300EQ47308518-B6642686-DE3E-4D88-B724-9887944A78BAQ48287834-5DBDFD3C-16FA-44A8-BEC4-E35064E71ACBQ52418969-04F7F83C-1476-4AB2-90CF-2209DCF574A8
P2860
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Radiographic response to neoad ...... vival in soft tissue sarcomas.
@en
type
label
Radiographic response to neoad ...... vival in soft tissue sarcomas.
@en
prefLabel
Radiographic response to neoad ...... vival in soft tissue sarcomas.
@en
P2093
P2860
P356
P1433
P1476
Radiographic response to neoad ...... vival in soft tissue sarcomas.
@en
P2093
Barry W Feig
Carl Plager
Datla G K Varma
Funda Meric
Kelly K Hunt
Kenneth R Hess
Kresimira M Milas
Michael A Burgess
Nicholas E J Papadopoulos
Peter W T Pisters
P2860
P304
P356
10.1002/CNCR.10794
P407
P577
2002-09-01T00:00:00Z